Adma Biologics reported $100.38M in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Adamis Pharmaceuticals ADMP:US USD 2.85M 4.2M
Adma Biologics ADMA:US USD 100.38M 14.02M
Agile Therapeutics AGRX:US USD 6.26M 2.84M
Alnylam Pharmaceuticals ALNY:US USD -67638000 243.68M
Biocryst Pharmaceuticals BCRX:US USD -242659000 29.43M
Minerva Neurosciences NERV:US USD -14246000 5.86M
Novavax NVAX:US USD -565985000 149.04M
Omeros OMER:US USD -46314000 13.61M
Takeda 4502:JP JPY 6.71T 396.1B